These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 32882538)
1. Elevated tumor-to-liver standardized uptake value ratio (TLR) from preoperative Wu C; Cui Y; Zhao Y; Chen X; Liao X; Di L; Yin L; Liu M; Wang R Eur J Radiol; 2020 Oct; 131():109218. PubMed ID: 32882538 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance and prognostic value of preoperative Chen S; Zhao Y; Tang Q; Wu C; Wang A; Ma L; Zhang X; Chen J; Gao Y; Liao X; Feng N; Fan Y; Zhang J; Li X; Liu M Cancer Imaging; 2022 Nov; 22(1):65. PubMed ID: 36435856 [TBL] [Abstract][Full Text] [Related]
3. 2-[ Zhao Y; Wu C; Li W; Chen X; Li Z; Liao X; Cui Y; Zhao G; Liu M; Fu Z Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):570-579. PubMed ID: 32814979 [TBL] [Abstract][Full Text] [Related]
4. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[ Wu C; Cui Y; Liu J; Ma L; Xiong Y; Gong Y; Zhao Y; Zhang X; Chen S; He Q; Zhang J; Liu M; Fan Y Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4054-4066. PubMed ID: 33978830 [TBL] [Abstract][Full Text] [Related]
5. Elevated tumor-to-liver uptake ratio (TLR) from Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients With Renal Cell Carcinoma. Nakajima R; Matsuo Y; Kondo T; Abe K; Sakai S Clin Nucl Med; 2017 Apr; 42(4):e177-e182. PubMed ID: 28134692 [TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of Betsunoh H; Sakamoto S; Kaji Y; Nukui A; Kobayashi M; Yashi M; Hayashi K; Anzai N; Kamai T Anticancer Res; 2021 Oct; 41(10):5179-5188. PubMed ID: 34593470 [TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation. Zhu H; Zhao S; Zuo C; Ren F AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159 [No Abstract] [Full Text] [Related]
9. Head-to-head comparisons of enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT in identifying adverse pathology of clear-cell renal cell carcinoma: a prospective study. Chen SH; Lin BH; Chen SM; Qiu QR; Ruan ZT; Chen ZJ; Wei Y; Zheng QS; Xue XY; Miao WB; Xu N Int Braz J Urol; 2023; 49(6):716-731. PubMed ID: 37624658 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353 [TBL] [Abstract][Full Text] [Related]
11. Primary tumor standardized uptake value (SUVmax) measured on Hui Z; Wei F; Ren H; Xu W; Ren X J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919 [TBL] [Abstract][Full Text] [Related]
12. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
13. One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival. Ito H; Kondo K; Kawahara T; Kaneta T; Tateishi U; Ueno D; Namura K; Kobayashi K; Miyoshi Y; Yumura Y; Makiyama K; Hayashi N; Hasumi H; Osaka K; Yokomizo Y; Teranishi JI; Hattori Y; Inoue T; Uemura H; Yao M; Nakaigawa N Cancer Chemother Pharmacol; 2017 May; 79(5):855-861. PubMed ID: 28331985 [TBL] [Abstract][Full Text] [Related]
14. Metabolic tumour volume on Kim D; Lee N; Lee SH; Kim HJ; Hong HS; Park JS; Cho NH; Choi YD; Ham WS; Lee SH; Han WK; Yun M Sci Rep; 2021 Dec; 11(1):23486. PubMed ID: 34873277 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of TLR from FDG PET/CT in patients with margin-negative stage IB and IIA non-small cell lung cancer. Park HL; Boo SH; Park SY; Moon SW; Yoo IR Eur Radiol; 2023 Oct; 33(10):7274-7283. PubMed ID: 37060445 [TBL] [Abstract][Full Text] [Related]
16. Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714 [TBL] [Abstract][Full Text] [Related]
17. Lesion detection by [ Verhoeff SR; van Es SC; Boon E; van Helden E; Angus L; Elias SG; Oosting SF; Aarntzen EH; Brouwers AH; Kwee TC; Heskamp S; Hoekstra OS; Verheul H; van der Veldt AAM; de Vries EGE; Boerman OC; van der Graaf WTA; Oyen WJG; van Herpen CML Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1931-1939. PubMed ID: 31172212 [TBL] [Abstract][Full Text] [Related]
18. Head-to-head comparison of [ Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis. Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]